Results 41 to 50 of about 644,370 (183)

AROMATASE INHIBITORS - TYPES AND ADVANTAGES [PDF]

open access: yes, 2016
The role of aromatase inhibitors in the management of breast cancer has been promising as it markedly suppresses the production of estrogen. The inhibitors are very effective in postmenopausal women and used as the first line therapy for hormone ...
C., Sudandiradoss, C., Benedict Paul
core   +1 more source

Aromatase Inhibitors for Ovulation Induction [PDF]

open access: yesThe Journal of Clinical Endocrinology & Metabolism, 2015
Normogonadotropic anovulation, including polycystic ovary syndrome (PCOS), is one of the main causes of infertility. Recent meta-analysis and randomized controlled trial suggest the use of aromatase inhibitors (ie, letrozole) as effective drug and first-line treatment to restore fertility in these patients.
openaire   +3 more sources

Depsidones inhibit aromatase activity and tumor cell proliferation in a co-culture of human primary breast adipose fibroblasts and T47D breast tumor cells

open access: yesToxicology Reports, 2017
Naturally occurring depsidones from the marine fungus Aspergillus unguis are known to have substantial anti-cancer activity, but their mechanism of action remains elusive. The purpose of this study was to examine the anti-aromatase activity of two common
Suthat Chottanapund   +8 more
doaj   +1 more source

Evaluation of Inhibitory Effect and Docking Study of Triazolyl Chromanone Oxime Ether Derivatives on Aromatase Enzyme Effective in Breast Cancer [PDF]

open access: yesJournal of Mazandaran University of Medical Sciences, 2023
Background and purpose: The spread of cancer, coupled with the challenges posed by complex treatments, stands as one of the foremost medical issues in today's world.
Roshanak Hariri   +5 more
doaj  

Aromatase Inhibitors in the Treatment of Endometriosis

open access: yes, 2011
Current treatment of endometriosis is mainly based on surgery and ovarian suppressive agents. In the last 10 years, it has been demonstrated that aromatase P450, a key enzyme for estrogen biosynthesis, may have a pathogenic role in endometriosis because ...
Remorgida V, Ferrero S, Venturini PL
core   +3 more sources

Facile Synthesis of Chrysin-derivatives with Promising Activities as Aromatase Inhibitors

open access: yesNatural Product Communications, 2011
Flavones such as chrysin show structural similarities to androgens, the substrates of human aromatase, which converts androgens to estrogens. Aromatase is a key target in the treatment of hormone-dependent tumors, including breast cancer.
Hamdoon A. Mohammed   +10 more
doaj   +1 more source

The emerging use of aromatase inhibitors for endometriosis treatment

open access: yesReproductive Biology and Endocrinology, 2011
Endometriosis is defined as the growth of endometrial tissue outside of the uterine cavity. The disease occurs primarily in women of reproductive age but recurrent endometriosis is also detected in post-menopausal women.
Nothnick Warren B
doaj   +1 more source

Study of Aromatase-Catalyzed Metabolic Switching of 2,2-Dimethylandrostenedione : Synthesis of Possible Metabolites and Their Inhibitory Activities of Aromatase [PDF]

open access: yes, 2004
Aromatase is a cytochrome P-450 enzyme responsible for the conversion of androgens to estrogens. 2,2-Dimethylandrostenedione (5) is one of the powerful inhibitors of the enzyme.
山田, 恵子   +11 more
core  

Tactics for minimizing risk of increasing estradiol against the background of aromatase inhibitors in combination with gonadotropin releasing hormone agonists in adjuvant therapy for breast cancer in premenopausal patients. Pilot study results

open access: yesМедицинский совет, 2018
Aromatase inhibitor (AI) combined with Gonadotropin-releasing hormone agonist (GnRH-a) have been recognized as an effective approach to adjuvant endocrinotherapy for breast cancer (BC) in premenopausal patients with adverse predictive factors.
I. B. Kononenko   +4 more
doaj   +1 more source

A non-synonymous coding change in the CYP19A1 gene Arg264Cys (rs700519) does not affect circulating estradiol, bone structure or fracture [PDF]

open access: yes, 2011
Background The biosynthesis of estrogens from androgens is catalyzed by aromatase P450 enzyme, coded by the CYP19A1 gene on chromosome 15q21.2. Genetic variation within the CYP19A1 gene sequence has been shown to alter the function of the enzyme.
Mullin, B.   +33 more
core   +2 more sources

Home - About - Disclaimer - Privacy